Semaglutide Treatment On Coronary Progression
Clinical trial NCT03985384 · COMPLETED
Trial details
- NCT number
- NCT03985384
- Sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-30
- Primary completion
- 2022-12-27
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.